ACCELERON PHARMA INC·4

Mar 5, 5:16 PM ET

Rovaldi Christopher 4

4 · ACCELERON PHARMA INC · Filed Mar 5, 2018

Insider Transaction Report

Form 4
Period: 2018-03-01
Rovaldi Christopher
SVP, Program Mgmt and Ops
Transactions
  • Award

    Common Stock

    2018-03-01+4,06328,764 total
  • Award

    Option to Purchase Common Stock

    2018-03-01+24,37524,375 total
    Exercise: $40.61Exp: 2028-03-01Common Stock (24,375 underlying)
Footnotes (1)
  • [F1]The shares of common stock underlying this stock option award vest in equal quarterly installments over the four years after January 1, 2018.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -